Pure Bioscience, Inc. (PURE): Capital Expenditures
Older than the company's other figures. The latest Capital Expenditures is for the year ended 2023-07-31, while the company's latest annual report covers the year ended 2025-07-31. Its later filings do not report this line under the concept TickerFacts maps.
$33.0K
Year ended 2023-07-31
-17.1%
3-year compound annual growth
+11.7%
5-year compound annual growth
+10.6%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2023-07-31 | $33.0K | -59.3% | 2024-10-29, From 2022-08-01 |
| 2022-07-31 | $81.0K | -84.5% | 2023-10-30, From 2021-08-01 |
| 2021-07-31 | $521.0K | +798.3% | 2022-10-28, From 2020-08-01 |
| 2020-07-31 | $58.0K | +728.6% | 2021-10-28, From 2019-08-01 |
| 2019-07-31 | $7.0K | -63.2% | 2020-10-08, From 2018-08-01 |
| 2018-07-31 | $19.0K | -90.8% | 2019-10-30, From 2017-08-01 |
| 2017-07-31 | $206.0K | -47.2% | 2018-10-25, From 2016-08-01 |
| 2016-07-31 | $390.0K | +381.5% | 2017-10-26, From 2015-08-01 |
| 2015-07-31 | $81.0K | +285.7% | 2016-10-27, From 2014-08-01 |
| 2014-07-31 | $21.0K | +75.0% | 2015-10-28, From 2013-08-01 |
| 2013-07-31 | $12.0K | +20.0% | 2014-10-28, From 2012-08-01 |
| 2012-07-31 | $10.0K | -28.6% | 2013-10-24, From 2011-08-01 |
| 2011-07-31 | $14.0K | n/a | 2012-10-29, From 2010-08-01 |